Advertisement

Topics

Cynvenio Biosystems, LLC Company Profile

03:52 EST 19th November 2017 | BioPortfolio

Cynvenio Biosystems is dedicated to the development and commercialization of high performance instruments and assays to support the R&D market in life sciences. Our initial goal is to accelerate the work of organizations focusing on cancer research, stem cells and the discovery and validation of novel therapeutic solutions. Cynvenio's innovative Micro-Magnetic Separation (MMS) platform uses patented techniques to reproducibly create large magnetic force fields within our proprietary microfluidic devices.

Location

2260 Townsgate Road, Unit 2
Westlake Village
CA
91361
United States of America

Contact

Phone: +1-805-777-0017
Email: info@cynvenio.com


News Articles [109 Associated News Articles listed on BioPortfolio]

Cynvenio Announces New LiquidBiopsy® Test for PD-L2 Expression

Westlake Village, CA (PRWEB) September 06, 2017 Cynvenio Biosystems, Inc., a leader in liquid biopsy testing technology for personal...

Cynvenio Announces New Deployment of LiquidBiopsy® System at Leading Cancer Research Center in South Korea

Westlake Village, CA (PRWEB) July 27, 2017 Cynvenio Biosystems, Inc. a leader in liquid biopsy technology for cancer research and ...

Cynvenio Announces New LiquidBiopsy® Test for PD-L2 Expression

Company launches the first commercially available liquid biopsy test for measuring PD-L2 expression in tumor cells. The test provides clinical researchers the ability to study how an individual’s ex...

Cynvenio and Saint Luke’s Cancer Institute Launch Pilot Study to Evaluate the Potential for Early Detection of Recurrent Breast Cancer Following Therapy

Westlake Village, CA (PRWEB) August 17, 2017 Cynvenio Biosystems, Inc., a leader in liquid biopsy technology for cancer research and...

Cynvenio Announces New LiquidBiopsy Test for PD-L1 Expression in Lung Cancer

New high sensitivity PD-L1 expression test provides real time information to support treatment strategy and patient monitoring Westlake Village, CA (PRWEB) August 08, 2017 Cynvenio Biosystems, Inc. a...

Cynvenio Launches Newest LiquidBiopsy HER2 Expression Test

High sensitivity blood test allows measurement of HER2 over-expression in patients after primary tumor has been removed and tissue biopsy is no longer available - provides novel way to monitor treatme...

Cynvenio Announces New Deployment of LiquidBiopsy® System at Leading Cancer Research Center in South Korea

LiquidBiopsy automated rare cell isolation platform enables quick-turnaround sample-to-sequence workflows at Gangnam Severance Hospital, supporting cancer research and genomic testing of cancer pati...

Cynvenio and Saint Luke’s Cancer Institute Launch Pilot Study to Evaluate the Potential for Early Detection of Recurrent Breast Cancer Following Therapy

New Study will use LiquidBiopsy® ClearID® testing and NK Score™ natural killer cell activity testing to monitor breast cancer patients following neoadjuvant chemotherapy. Westlake Village,...

Drugs and Medications [0 Results]

None

PubMed Articles [44 Associated PubMed Articles listed on BioPortfolio]

Front cover.

Back cover.

Contents list.

Second law efficiency for living cells.

The exergetic analysis of the biosystems is developed. It takes into account that cells are able to convert only part of the energy absorbed. The result is to highlight the fundamental role of the exe...

Proximity aptasensor for protein detection based on an enzyme-free amplification strategy.

A novel electrochemical aptasensor for the detection of trace protein is proposed based on proximity binding-induced strand displacement and hybridization chain reaction. This method is proven to be h...

Clinical Trials [0 Results]

None

Companies [103 Associated Companies listed on BioPortfolio]

Cynvenio Biosystems, LLC

Cynvenio Biosystems is dedicated to the development and commercialization of high performance instruments and assays to support the R&D market in life sciences. Our initial goal is to accelerate the w...

Cynvenio Biosystems, Inc.

Cynvenio Biosystems, Inc. is a privately held company focused on the development of high performance cell isolation technology for biomedical research and novel cancer diagnostics...

BioMolded Products LLC

BioMolded Products LLC, a subsidiary of Cynvenio Biosystems, Inc., is based in Westlake Village, California and specializes in continuous extrusion blow molding.  The Company i...

X2 Biosystems

X2 Biosystems is a privately held Seattle-based science and technology company that has developed the world’s first systems for comprehensive, end-to-end, real-time managemen...

Silicon Biosystems, Inc.

Silicon Biosystems, Inc. was formed in October of 2010 as a wholly owned subsidiary of Silicon Biosystems, S.p.A. based in Bologna, Italy. The Company manufactures and sells the D...

More Information about "Cynvenio Biosystems, LLC" on BioPortfolio

We have published hundreds of Cynvenio Biosystems, LLC news stories on BioPortfolio along with dozens of Cynvenio Biosystems, LLC Clinical Trials and PubMed Articles about Cynvenio Biosystems, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cynvenio Biosystems, LLC Companies in our database. You can also find out about relevant Cynvenio Biosystems, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record